Compare PRCH & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRCH | IRWD |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 880.9M | 741.8M |
| IPO Year | 2019 | 2009 |
| Metric | PRCH | IRWD |
|---|---|---|
| Price | $8.20 | $3.42 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | ★ $17.11 | $4.94 |
| AVG Volume (30 Days) | 2.0M | ★ 2.7M |
| Earning Date | 05-13-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 90.91 | ★ 1400.00 |
| EPS | N/A | ★ 0.15 |
| Revenue | ★ $482,414,000.00 | $298,276,000.00 |
| Revenue This Year | $2.37 | $41.42 |
| Revenue Next Year | $16.96 | $16.01 |
| P/E Ratio | ★ N/A | $22.53 |
| Revenue Growth | ★ 10.18 | 8.88 |
| 52 Week Low | $4.65 | $0.55 |
| 52 Week High | $19.44 | $5.78 |
| Indicator | PRCH | IRWD |
|---|---|---|
| Relative Strength Index (RSI) | 51.69 | 35.12 |
| Support Level | $6.36 | $3.15 |
| Resistance Level | $9.89 | $3.53 |
| Average True Range (ATR) | 0.64 | 0.37 |
| MACD | 0.07 | -0.16 |
| Stochastic Oscillator | 46.37 | 23.79 |
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.